Researchers sought to validate the modified Erasmus GBS Outcome Score, a clinical model that predicts the inability to walk in patients with GBS, in the International GBS Outcome Study cohort, observe any regional variations in performance, and improve predictions by adjusting accordingly.
In a prospective natural history study, researchers tested the association between body mass index and height and clinical characteristics in Friedreich ataxia.
The application is supported by data from the phase 3 study that evaluated the efficacy and safety of ravulizumab-cwvz in 175 adults with generalized myasthenia gravis who were not previously treated with a complement inhibitor.
Vyvgart (efgartigimod), a neonatal Fc receptor blocker, was approved to treat generalized myasthenia gravis in adults who test positive for the anti-acetylcholine receptor antibody.
Researchers sought to develop a “roadmap” to early intervention and disease prevention for ALS by observing advances in neurodegenerative diseases with a presymptomatic period.
Using similarity network fusion and spectral clustering, researchers sought to identify ALS disease subphenotypes and whether different patterns of disruption are predictive of outcome.
Using Medicare claims data, researchers determined whether there is an increased risk of developing Guillain-Barré syndrome following vaccination with the zoster vaccine.
